[1]
Sridhar, S.S. 2019. Balancing efficacy and financial toxicity in the management of metastatic castration-sensitive prostate cancer . Canadian Urological Association Journal. 13, 12 (Nov. 2019), 404-5. DOI:https://doi.org/10.5489/cuaj.6346.